Leicestershire Health Community
Medicines Formulary
 
back
3 Respiratory system
03-02-02 Compound Corticosteroid/ Long acting beta-agonist inhalers

Budesonide and Formeterol Fobumix Easyhaler®
Formulary

For adults and children 18 years and over.


Green View adult BNF  View SPC online
Budesonide and Formoterol  DuoResp Spiromax®
Formulary
First choice for patients aged 18 years and older.
Prescribe by brand as devices are not interchangeable
To be used only in new patients or after a review by a healthcare professional and counselling of patient to ensure appropriate use of the device.
There is no MART/SMART® equivalent with DuoResp.

Green View adult BNF  View SPC online
Budesonide and formoterol Symbicort®
Formulary
Licensed from 6 years for maintenance therapy (SMART programme from 12). First choice in children 6-18 or in over 12s requiring the SMART programme.


Symbicort SMART® programme for flexibly adjusting dose – see supporting information (link below) Licensed for this in those 12 years and over.

Prescribe by brand as generic preparations available are a different device and are not interchangeable
Link  Supporting information
 

Green View adult BNF  View SPC online
Formoterol and beclometasone Fostair®
Formulary
ASTHMA: Treament option where a combination is appropriate in patients 18 and over who can’t utilise the Symbicort Turbohaler® or where there is a preference for an MDI.
COPD: Alternative choice where MDI is required
Fostair® is licensed for use with the AeroChamber Plus spacer device. It is stored in the refrigerator until dispensed after which it is given a 5 month expiry date.
Fostair® MART programme for flexibly adjusting dose is available with 100/6 inhaler
Link  Leicestershire Evaluation: Fostair in Asthma
Link  Leicestershire Evaluation: Fostair in COPD
 

Green View adult BNF  View SPC online
Glycopyrronium, Beclometasone and Formoterol Trimbow®
Formulary

For maintenance of COPD

Use in line with COPD guidelines


Green View adult BNF  View SPC online
Formoterol and beclometasone Fostair NEXThaler®
Formulary
Dry powder inhaler, available as 200/6 and 100/6.
Asthma:To be used in line with Adult asthma guidance and combination inhaler step down guidance.
COPD: 200/6 is not licensed for use in COPD. To be used in line with COPD guidance and step down ICS guideline

Green View adult BNF  View SPC online
Fluticasone and salmeterol Seretide®
Restricted
ASTHMA: First choice in patients aged 5-12 years, where an ICS/LABA MDI is required. Over 12 years, follow adult guidelines.
Compared to other combination products there is less flexibility in dosage adjustment.

COPD: Non Formulary for this indication

Restricted Drug Green View adult BNF  View SPC online